Over 141 Acres Allocated for Pharma Park in Naya Raipur to Boost Healthcare and Economy
Chhattisgarh as a leading pharmaceutical hub in central India, the state government has allocated over 141 acres of land in Sector-22 of Naya Raipur for the development of a pharmaceutical park. This initiative, led by the Naya Raipur Atal Nagar Development Authority, marks a significant move to foster research, innovation, and investment in the growing pharmaceutical sector. The Chhattisgarh State Industrial Development Corporation (CSIDC) has received the land allocation, and the development of this park is expected to have far-reaching impacts on the state’s healthcare services and economic growth.
Chhattisgarh’s push to improve healthcare access and its infrastructure aligns with the state’s vision to become a prominent player in the pharmaceutical industry. The project is set to create a strong base for pharmaceutical units, with a particular focus on Ayush (alternative medicine) products. The state government sees this as a critical part of its broader efforts to improve health services for its citizens and attract both domestic and international investments. The pharmaceutical park will be equipped with state-of-the-art infrastructure, including a flatted factory complex and a common effluent treatment plant (CETP). This modern facility will support research and development centres, as well as testing laboratories, essential for fostering innovation and ensuring the quality of products manufactured within the park. The park will not only contribute to the domestic supply of healthcare products but is also poised to meet the increasing demand for pharmaceutical products in global markets.
The Chhattisgarh government has been proactive in implementing policies that attract investment in the pharmaceutical sector. Under the new industrial policy (2024-30), the state offers substantial incentives for pharmaceutical industries. These include a 100% investment promotion for large-scale enterprises, reimbursement of up to 100% of net SGST paid for 12 years from the start of production, and capital investment grants. The grants offered to investors depend on the scale of their investment: Rs 60 crore for investments between Rs 50-200 crore, Rs 150 crore for investments between Rs 200-500 crore, and Rs 300 crore for investments exceeding Rs 500 crore. These generous incentives are aimed at making the pharmaceutical park in Naya Raipur an attractive destination for both Indian and international pharmaceutical companies. The state government has also introduced additional benefits, such as a 12-year exemption on electricity charges, stamp duty waivers, and a 50% reimbursement on registration fees and electricity connection charges.
Beyond economic benefits, the establishment of this park also aims to create significant employment opportunities for local youth, contributing to the state’s economic development. The government spokesperson highlighted that the state is already making strides in healthcare accessibility, with over 77 lakh families benefiting from free treatment under the Shaheed Veer Narayan Singh Ayushman Health Scheme. This initiative aims to expand the coverage to Rs 10 lakh per family in the near future, further enhancing healthcare accessibility. Chhattisgarh’s push to develop this pharmaceutical park underscores its commitment to strengthening its healthcare infrastructure and becoming a key player in the pharmaceutical industry. By offering a conducive environment for investment, innovation, and employment, the state is setting the stage for future growth in both the healthcare and industrial sectors.
